IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
76 hedge funds and large institutions have $59.4M invested in Insight Molecular Diagnostics Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 23 closing their positions.
Holders
76
Holders Change
-10
Holders Change %
-11.63%
% of All Funds
1.29%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
15
Increased
15
Reduced
26
Closed
23
Calls
$156K
Puts
–
Net Calls
+$156K
Net Calls Change
-$77K
Top Buyers
1 |
AIC
1
AWM Investment Company
New York
|
$6.97M |
2 |
BC
2
Broadwood Capital
New York
|
$21M |
3 |
PVI
3
Pura Vida Investments
New York
|
$16.2M |
4 |
4
Millennium Management
New York
|
$896K |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$3.91M |